课题基金 / 基金详情

Characterization of Newly Discovered Proteins that Inhibit the CRISPR/Cas Adaptive Immunity Systems of Bacteria

Characterization of Newly Discovered Proteins that Inhibit the CRISPR/Cas Adaptive Immunity Systems of Bacteria
新发现的抑制细菌 CRISPR/Cas 适应性免疫系统的蛋白质的表征
批准号:
282206
负责人:
Davidson Alan R
金额:
$73.02万
依托单位:
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2013
资助国家:
加拿大
项目状态:
已结题
起止时间:
2013-03-01 至 2018-03-01

项目摘要

项目成果

Davidson Alan R的其他基金

相似基金

相关文献

中文摘要
翻译
近年来,已经非常清楚的是,生活在人体内和人体表面的微生物,也被称为“人体微生物组”,在人体生理学,免疫力和营养中起着至关重要的作用。尽管细菌是迄今为止数量最多的细胞,
英文摘要
In recent years it has become abundantly clear that microorganisms living within and on humans, also referred to as the 'human microbiome', play a crucial role in human physiology, immunity and nutrition. Although bacteria are by far the most numerous cel
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Investigating the battle between CRISPR-Cas systems and anti-CRISPRs using biochemical, genetic, and evolutionary approaches
  • 批准号:
    480052
  • 项目类别:
    Operating Grants
  • 资助金额:
    $82.76万
  • 财政年份:
    2023
  • 负责人:
    Davidson Alan R
  • 依托单位:
Canada Research Chair - Tier 1 - CIHR Funded
  • 批准号:
    384866
  • 项目类别:
  • 资助金额:
    $101.99万
  • 财政年份:
    2017
  • 负责人:
    Davidson Alan R
  • 依托单位:
Developing phage tail-derived nanomachines as strain specific antibacterial agents
  • 批准号:
    358137
  • 项目类别:
    Operating Grants
  • 资助金额:
    $68.83万
  • 财政年份:
    2016
  • 负责人:
    Davidson Alan R
  • 依托单位:
Exploring the evolutionary battle between phages and bacteria: from CRISPR-Cas systems to phage-derived antibacterial weapons
  • 批准号:
    355205
  • 项目类别:
    Operating Grants
  • 资助金额:
    $301.74万
  • 财政年份:
    2016
  • 负责人:
    Davidson Alan R
  • 依托单位:
海外基金